Page 99 - TIF2018 | UNITED STATES PAVILION EXHIBITORS CATALOGUE

Zachary Ragousis

President and Managing Director of Pfizer Hellas S.A.

– How important is Creativity and Innovation to your business?
Innovation is a concept that goes hand-in-hand with a man's efforts to live better and, when it
comes to health, longer.
The concepts of creativity and innovation fully coincide with our company's strategy for
consistently and reliably meeting the needs of patients over time.
Our company's goal is to be the premier, innovative biopharmaceutical company worldwide,
putting "Patients First" philosophy into practice.
We invest in fields that are at the cutting edge of technology in order to cover the unfulfilled needs
of patients, and in doing so we operate on our own or in collaboration with other companies. We
have also entered the field of gene therapy.
– What was the key element that drove you in USATIF2018 (regional opportunities, Greece’s
recent reforms, etc.)?
This is a first-class opportunity to highlight the innovations of the pharmaceutical industry, which
will not only help to improve the health and quality of life of Greek patients, but will also contribute
to achieving the national goal of financial growth and job creation in Greece.
Pfizer Hellas has been in Greece since 1960 and in its many years of operation in the country, it has
made significant investments in innovation and research.
Throughout this time, we have contributed hundreds of millions of euros to the country's public
revenues and we have given employment and professional growth opportunities to thousands of
workers, both in-house employees and associates.
– What will be the highlight of your presence in USATIF2018, is there anything "new" that you are
planning to present?
By taking advantage of contemporary and interactive media, we plan to demonstrate how the
concept of innovation fully coincides with our company's strategy for consistently and reliably
meeting the needs of patients over time.
We also plan to present our constant and consistent efforts to speed up the development of
innovative medicines and treatments through scientific advancements in order to cover any needs,
from a single patient with a rare condition to many millions of patients throughout the world.

97